BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28231593)

  • 21. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
    Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
    J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment.
    Furuuchi K; Nishiyama A; Yoshioka H; Yokoyama T; Ishida T
    Respir Investig; 2017 Mar; 55(2):184-187. PubMed ID: 28274537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues.
    Zhuang H; Shi S; Yuan Z; Chang JY
    Mol Cancer; 2019 Feb; 18(1):21. PubMed ID: 30732625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose bevacizumab for radiation-induced brain necrosis: a case report.
    Panagiotou E; Charpidou A; Fyta E; Nikolaidou V; Stournara L; Syrigos A; Gkiozos I
    CNS Oncol; 2023 Sep; 12(3):CNS98. PubMed ID: 37140173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas.
    Furuse M; Nonoguchi N; Kawabata S; Miyata T; Toho T; Kuroiwa T; Miyatake S
    Radiat Oncol; 2015 Jul; 10():156. PubMed ID: 26223253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.
    Foster KA; Ares WJ; Pollack IF; Jakacki RI
    Pediatr Blood Cancer; 2015 Feb; 62(2):240-245. PubMed ID: 25382690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of radiation dose on the onset and progression of radiation-induced brain necrosis in the rat model.
    Hartl BA; Ma HSW; Hansen KS; Perks J; Kent MS; Fragoso RC; Marcu L
    Int J Radiat Biol; 2017 Jul; 93(7):676-682. PubMed ID: 28306402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.
    Ruben JD; Dally M; Bailey M; Smith R; McLean CA; Fedele P
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):499-508. PubMed ID: 16517093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
    Lubelski D; Abdullah KG; Weil RJ; Marko NF
    J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
    Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
    J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review.
    Rahmathulla G; Recinos PF; Valerio JE; Chao S; Barnett GH
    Stereotact Funct Neurosurg; 2012; 90(3):192-200. PubMed ID: 22678505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia.
    Pillay Smiley N; Alden T; Hartsell W; Fangusaro J
    Pediatr Blood Cancer; 2016 Sep; 63(9):1671-3. PubMed ID: 27187113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of radiation necrosis of the central nervous system treated with bevacizumab.
    Tye K; Engelhard HH; Slavin KV; Nicholas MK; Chmura SJ; Kwok Y; Ho DS; Weichselbaum RR; Koshy M
    J Neurooncol; 2014 Apr; 117(2):321-7. PubMed ID: 24504500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Cerebral Radiation Necrosis: A Retrospective Study of 12 Patients.
    Liao C; Visocchi M; Zhang W; Yang M; Zhong W; Liu P
    Acta Neurochir Suppl; 2017; 124():195-201. PubMed ID: 28120074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reorganization of functional areas of the brain after brain irradiation.
    Brockmann S; Grummich P; Ganslandt O; Fietkau R; Semrau S
    J Clin Oncol; 2011 Apr; 29(12):e321-3. PubMed ID: 21263098
    [No Abstract]   [Full Text] [Related]  

  • 37. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
    Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
    Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Late radiation brain necrosis: a brain tumor like mass].
    Zhao RL
    Zhonghua Wai Ke Za Zhi; 1993 Nov; 31(11):676-8. PubMed ID: 8033692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 inhibition to treat radiation-induced brain necrosis and edema.
    Khan RB; Krasin MJ; Kasow K; Leung W
    J Pediatr Hematol Oncol; 2004 Apr; 26(4):253-5. PubMed ID: 15087954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience.
    Climans SA; Ramos RC; Jablonska PA; Shultz DB; Mason WP
    Can J Neurol Sci; 2023 Jul; 50(4):573-578. PubMed ID: 35634744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.